Welcome to KidneyX

Learn More

What is KidneyX?

The Kidney Innovation Accelerator (KidneyX) is a public-private partnership between the US Department of Health and Human Services and the American Society of Nephrology to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases. KidneyX seeks to improve the lives of the 850 million people worldwide currently affected by kidney diseases by accelerating the development of drugs, devices, biologics and other therapies across the spectrum of kidney care including:

Prevention

Diagnostics

Treatment

Learn More

Guiding KidneyX

Mission

Accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases

Principles

  • Patient-Centered Ensure all product development is patient-centered
  • Urgent Create a sense of urgency to meet the needs of people with kidney diseases
  • Achievable Ground in scientifically-driven technology development
  • Catalytic Reduce regulatory and financial risks to catalyze investment in kidney space
  • Collaborative Foster multidisciplinary collaboration including innovators throughout science and technology, the business community, patients, care partners, and other stakeholders
  • Additive Address barriers to innovation public/private sectors do not otherwise
  • Sustainable Invest in a diverse portfolio to balance risk and sustain KidneyX

Learn More

How will KidneyX Succeed?

Building off the success of similar public-private accelerators, KidneyX will engage a community of researchers, innovators, and investors to bring breakthrough therapies to patients by:

Development

Driving patient access to disruptive technologies via competitive, non-dilutive funding to innovators.

Coordination

Providing a clearer and less expensive path to bringing products to patients and their families.

Urgency

Creating a sense of urgency by spotlighting the immediate needs of patients and their families.

Get Involved

Interested in being part of the KidneyX solution? Enter your email address to join the mailing list:

Submit

Learn More

Kidney Disease Statistics

0

A typical in-center hemodialysis patient spends 12 hours a week attached to a machine

Source: Report to Congressional Requesters: National Institutes of Health – Kidney Disease Research Funding and Priority Setting; United States Government Accountability Office; December 2016.

0

Among patients ages 18-54 years old at the start of dialysis, 93% were classified as disabled

Source: Erickson K, et al. Employment among Patients Starting Dialysis in the United States. Clinc J. Am Soc Nephrol 13: 265-273, 2018.

0

Each year, more than 100,000 Americans begin hemodialysis as a result of kidney failure

Source: United States Renal Data System. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2017.

0

40 Million adult Americans are currently classified as having chronic kidney disease

Source: Report to Congressional Requesters: National Institutes of Health – Kidney Disease Research Funding and Priority Setting; United States Government Accountability Office; December 2016.

0

Every day 13 patients die waiting for a kidney transplant

Source: Mitchell K. For Transplant Patients, 'This is Your Statue of Liberty'. GW Magazine. http://magazine.gwu.edu/for-transplant-patients. Published December 2, 2016. Accessed March 2018.

0

Of Stage 4 CKD patients, 48% were unaware of their severe CKD

Source: United States Renal Data System. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2017.

0

African-Americans are 3.5x more likely to develop kidney failure

Source: Kidney Disease Statistics for the United States. National Institute of Diabetes and Digestive Kidney Diseases. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease. Published December 2016. Accessed March 2018.

0

Hispanics are 1.5x more likely to develop kidney failure

Source: Kidney Disease Statistics for the United States. National Institute of Diabetes and Digestive Kidney Diseases. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease. Published December 2016. Accessed March 2018.

Redesign Dialysis Prize Competition

The first KidneyX prize competition is Redesign Dialysis: with this prize we're looking to accelerate the development and commercialization of next-generation dialysis products. Redesign Dialysis is a 2 phase prize: Phase 1 (submissions open now) asks participants to design possible solutions or solution components that can replicate normal kidney functions and improve patient quality of life. For Phase 1, we're awarding up to 15 prizes of $75,000 each. Phase 2 (planned to open in April 2019) will ask participants to develop and demonstrate prototype solutions. Phase 2 will have up to 3 awards of $500,000 each. You can participate and win in Phase 2 even if you didn't participate in Phase 1.

Check out our prize announcement for complete details about this prize competition, including eligibility, submission, and judging requirements.

Read More  Phase I FAQs  Submit Now

Here are some key points about Redesign Dialysis Phase 1:

Phase 1 submission period open now
Phase 1 submission period ends: February 28, 2019, 5:00 p.m. ET
Phase 1 Awardees announced by: April 30, 2019
Phase 2 begins: April 15, 2019

In Phase 1, we are looking for designs of solutions that will address at least one of the following areas:

  • Replicating Kidney Functions (Blood Filtration, Electrolyte Homeostasis, Fluid Regulation, Toxin Removal and Secretion, and/or Filtrate Drainage and Connectivity)

  • Improving Patient Quality of Life (e.g., minimizing burden on the family and care partner(s), reducing disease and treatment complications, increasing mobility and physical activity)

  • Improved renal replacement therapy access (vascular or peritoneal access)

  • Addressing engineering challenges (e.g., preventing clotting, bleeding, and infection in vascular circuit and associated devices)

  • Ancillary technologies

  • Biomaterials development

  • Biological and Immunological modulation

  • Biosensor development and other safety monitoring functions

For more specifics about current technical and scientific needs in the field, you can review Section F on the prize announcement or the Kidney Health Initiative's Technology Roadmap for Innovative Approaches to Renal Replacement Therapy.

Phase 1 submissions must be made through challenge.gov. Submissions should be no more than 6 pages. Submissions must also include a publicly-shareable abstract no longer than one page. You can add a visual supplement (video, website, design specs) in your submission if you would like.

Phase 1 evaluation criteria are:

  • Potential to significantly improve or add to the landscape of solutions to manage kidney failure.

  • Nature and extent of anticipated benefit(s) to patients (clearly demonstrating efforts to incorporate patient feedback into the design).

  • Feasibility of producing a functional prototype (including scientific and technological rigor).

  • Quality of evidence supporting the design.

Submit Your Solution

For information about Phase 2, its submission requirements, and its judging criteria, please look at the prize announcement.

For Further Information Contact:
Ross Bowling, Ph.D. (Ross.Bowling@hhs.gov, 202-260-7158) or
Sandeep Patel, Ph.D. (Sandeep.Patel@hhs.gov, 202-205-0355).

Learn More

KidneyX In The News

Kidney Disease Group Announces Roadmap for Innovative Treatments

The American Society of Nephrology's "Technology Roadmap for Innovative Approaches to Renal Replacement Therapy" aims to spark new ideas about how to treat kidney disease beyond dialysis. The roadmap lays out specific goals for therapy improvements, suggested time horizons, and the kinds of multidisciplinary collaborations required to make those improvements happen.

October 30, 2018

Accelerator Launches in San Diego to Find Better Kidney Disease Treatments

The Department of Health and Human Services and the American Society of Nephrology launched a $2.65 million challenge to seek better treatments for kidney disease. The program, called the KidneyX Innovation Accelerator, was launched at the American Society of Nephrology's annual meeting in San Diego.

October 23, 2018

The New HHS Kidney Innovation Accelerator: When Innovation Stalls, HHS Says Floor It!

In the fight against kidney disease, this is our moment as a community to look beyond the status quo and cynics and imagine the possible. The time is now to say "If not us, then who? And if not now, then when?"

October 20, 2018

President's Column: Kidney Innovation Accelerator

Mark D. Okusa, MD, FASN, President of the American Society of Nephrology, catalogues the need for innovation in nephrology and the potential of KidneyX to accelerate the development and commercialization of kidney therapeutics and improve the lives of patients with kidney diseases.

February 1, 2018

Trump Administration Proposes 'Kidney Innovation Accelerator Program'

The Department of Health and Human Services (HHS) has recently taken a critical step that will hopefully increase kidney disease research and therapy integration to the level it needs to be.

December 1, 2017

HHS to Launch Initiative Encouraging Innovation in Kidney Care

The Department of Health and Human Services announced last week that it will establish a public-private fund to help move new technology forward in treating kidney disease.

November 7, 2017

KidneyX Accelerator Raises Hopes for Innovation in Kidney Space

Innovation in kidney care promises to be a significant theme in the kidney community in 2018, and it is hoped, well beyond.

January 5, 2018

Sparking Innovation to Improve the Lives of People with Kidney Disease

In February of 2017, the VA and ASN convened the inaugural Kidney Innovation Summit at the BAH Innovation Center in Washington D.C. to identify opportunities for innovation in the care of people with CKD.

September 7, 2017

VA's Kidney Innovation Summit: Seeding Opportunities for Better Health

The Kidney Innovation Summit, convened by the VA Center for Innovation and ASN, brought together over 150 great minds to think through new approaches to prevent and treat kidney disease.

February 21, 2017

Frequently Asked Questions (FAQ)

What is KidneyX?

KidneyX, also called the Kidney Innovation Accelerator, is a public-private partnership between the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN). HHS is the Federal agency whose mission is to enhance and protect the health and well-being of all Americans. The HHS divisions participating in KidneyX include the Centers for Medicare and Medicaid Services (CMS), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH). Established in April 2018, KidneyX aims to use prize competitions to accelerate the development of innovative solutions that can prevent, diagnose, and/or treat kidney diseases. KidneyX aims to promote collaboration between patients, health professionals, innovators, industry, and government with the ultimate goal of improving quality of life for people living with kidney diseases.

KidneyX will:

1) Fund promising innovators through a series of prize competitions;

2) Encourage better coordination across the HHS agencies, including CMS, FDA, and NIH, to clarify the path toward commercialization and patient access to innovative products; and

3) Create a sense of urgency to develop new ways to prevent, diagnose, or treat kidney diseases.

What is a prize competition?

A prize competition is a method of problem-solving that describes a problem (usually to the general public) and offers a prize or prizes to whoever comes up with the best solution(s). Prize competitions are a good way to attract ideas and skills from a wide range of fields. Prize competitions only provide funding for solutions that meet the judging criteria established when the competition is announced.

How will KidneyX prize competitions work?

In its prize competitions, KidneyX will identify and describe a problem related to kidney disease that needs to be addressed (for example, finding a new class of kidney replacement therapeutic options for patients, empowering patients or designing better diagnostic tools). Each KidneyX prize competition announcement will outline that prize's eligibility rules, describe the submission process and prize, and explain the criteria for selecting winners. After the submission period ends, a panel of judges will select the winners from the submissions received.

What will the first KidneyX prize competition be, and when will it launch?

Currently, KidneyX has launched its first prize competition, Redesign Dialysis. plans to launch its first prize competition on October 25, 2018. This competition iswill focused on improving kidney replacement therapies for patients. You can learn more about this prize by reading the prize announcement or the Redesign Dialysis FAQs.

What will future KidneyX prize competitions be?

Future KidneyX prize competitions will cover a range of topics in kidney care. Possible topic areas include medications (a variety of treatments for kidney disease, including drugs and biologics), diagnostics (point-of-care or at-home testing kits, better tools to measure kidney function), patient-centered tools (electronic health record tools designed to identify and track disease, applications to empower patients to manage kidney disease), and next generation dialysis (wearable or implantable dialyzers, tissue engineering).

Does KidneyX provide grants?

KidneyX does not provide grants. Instead, KidneyX will operate a series of prize competitions (see What is a prize competition?).

How much funding will be available for prize competition winners?

Different KidneyX prize competitions will have different prize values. The Redesign Dialysis prize has a total prize purse of $2,625,000.

What is the timeframe for the first KidneyX prize competition?

While this timeframe is subject to change, Phase 1 submissions for Redesign Dialysis must be submitted via challenge.gov by 5:00 pm February 28, 2019. Phase 1 winners will be announced by April 30, 2019.

What kind of solutions are you seeking for the first KidneyX prize?

The Sections D and F of the official Redesign Dialysis announcement of the first KidneyX prize competition on October 25, 2018 will provideprovide more details about this. However, for the first prize competition, KidneyX is interested in solutions that can 1) help replicate kidney functions such as blood filtration, electrolyte homeostasis, fluid regulation, or toxin removal and secretion; or 2) improve patient quality of life (e.g., increase mobility, minimize intrusion of therapy on family and social life, reduce disease and treatment complications); or 3) improved kidney replacement therapy access (vascular, peritoneal, or blood circuit access needed for treatment); or 4) strengthen safety monitoring functions.

Is there specific FAQ for the Redesign Dialysis prize competition?

In order to clarify the Redesign Dialysis prize competition process, FAQ have been drafted and can be accessed here.

Who can apply to participate in KidneyX?

Anyone can apply to participate in KidneyX, either as individuals or teams. Each KidneyX prize competition announcement will include the eligibility rules (if any) for that prize.

KidneyX recognizes that many potential participants may have applicable technologies, concepts, or expertise from domains that have not previously been considered with regards to kidney diseases. One of KidneyX's biggest goals is to bring such technologies and expertise into the kidney space.

What sort of help will KidneyX provide to participants?

KidneyX plans to assist prize winners in a variety of ways. Because new innovators often lack experience in product commercialization, KidneyX plans to help prize winners receive input and feedback from patients, investors, business and manufacturing experts, scientists, engineers, regulators, payers, and others as needed.

How can my organization support KidneyX?

KidneyX is seeking additional partners. Organizations interested in supporting KidneyX (whether by providing financial resources, scientific expertise or other means) are encouraged to contact KidneyX staff at kidneyx@asn-online.org.

How can I stay informed about KidneyX?

To receive updates on KidneyX, please sign up for our e-mail list on KidneyX.org; you can also follow KidneyX on Twitter (@Kidney_X).

How can I contact KidneyX?

You can contact KidneyX via e-mail at kidneyx@asn-online.org.

Want to Learn More?

Contact KidneyX

Individuals that are interested in being part of the KidneyX solution are encouraged to contact KidneyX at kidneyx@asn-online.org to be placed on a mailing list.

Follow on Twitter: @Kidney_X

202-640-4660